Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Personalized Medicine and Minimally Invasive Procedures
4.2.2 Growing Burden of Chronic Disorders and Geriatric Population
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 High Cost Issues
4.3.2 Potential Health Risks associated with Smart Pills
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Smart Pill Boxes
5.1.2 Smart Pill Bottles
5.2 By Indication
5.2.1 Dementia
5.2.2 Cancer Management
5.2.3 Diabetes Care
5.2.4 Geriatric Care
5.2.5 Others
5.3 By End-User
5.3.1 Home Care Settings
5.3.2 Long Term Care Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 e-pill Medication Reminders
6.1.2 Group Medical Supply LLC
6.1.3 Medipense Inc.
6.1.4 Medminder, Inc.
6.1.5 MedReady
6.1.6 PharmRight Corporation
6.1.7 PillDrill Inc.
6.1.8 Pillo, Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS